Pregled bibliografske jedinice broj: 1203808
Effect of probiotic Lactobacillus reuteri as an adjunct to nonsurgical treatment on halitosis of patients with periodontitis - a preliminary randomised controlled trial.
Effect of probiotic Lactobacillus reuteri as an adjunct to nonsurgical treatment on halitosis of patients with periodontitis - a preliminary randomised controlled trial. // Abstracts of EuroPerio10. U: Journal of Clinical Periodontology 2022 ; 49(Supplement 23)
Frederiksberg: John Wiley & Sons, 2022. str. 24-25 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1203808 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Effect of probiotic Lactobacillus reuteri as an
adjunct to nonsurgical treatment on halitosis of
patients with periodontitis - a preliminary
randomised controlled trial.
Autori
Musić, Larisa ; Puhar, Ivan ; Vražić, Domagoj ; Badovinac, Ana ; Plančak, Darije
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of EuroPerio10. U: Journal of Clinical Periodontology 2022 ; 49(Supplement 23)
/ - Frederiksberg : John Wiley & Sons, 2022, 24-25
Skup
EuroPerio 10
Mjesto i datum
Kopenhagen, Danska, 15.06.2022. - 18.06.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Lactobacillus reuteri ; probiotics ; halitosis ; periodontitis ; nonsurgical periodontal treatment
Sažetak
Background and Aim: Intraoral halitosis is caused by microbial degradation of oral organic substrates, resulting in volatile compounds. Periodontitis may present as one of the oral conditions causative to halitosis. The aim of this randomised controlled trial was to assess the effect of probiotic Lactobacillus reuteri as an adjunct to nonsurgical periodontal treatment on halitosis of patients with periodontitis. Methods: 30 systemically healthy patients with generalised periodontitis stage II-IV and halitosis (OLS≥1 and VSC >160 ppb) were included in this trial. All patients were treated with nonsurgical periodontal treatment, after which they were randomly assigned to a test group, using probiotic lozenges for 28 days/twice per day (ProDentis®, BioGaia AB, Lund, Sweden) or a control group using placebo lozenges. Halitosis was assessed by organoleptic judgement and with a device (Halimeter®, Interscan Corporation Chatsworth, CA, USA) at baseline, after 1 month and 3 months. Tongue coating (WTCI)was assessed at baseline, after 1 month and 3 months. Clinical periodontal parameters, PPD, CAL, REC, FMBS and FMPS, were recorded at baseline and 3 months. Results: Both groups showed significant halitosis reduction, tongue coating reduction and improvements in periodontal parameters at 3 months. No significant inter-group differences could be detected for halitosis parameters at 1 and 3 months. A composite outcome for residual halitosis, defined as OLS≥1 and VSC >160 ppb present at 3 months, showed a marginally significant difference between the probiotic and control group (0% vs 20%, respectively, p=0.068) with greater nullification of halitosis in the probiotic group. The probiotic group showed small but significantly greater PPD reduction and CAL gain (p < 0.0001).Conclusions: Within the limitations of this study, it can be concluded that causative periodontal treatment is effective in halitosis reduction, and probiotics could provide additional benefit.
Izvorni jezik
Engleski
Znanstvena područja
Dentalna medicina
POVEZANOST RADA
Ustanove:
Stomatološki fakultet, Zagreb
Profili:
Ivan Puhar
(autor)
Ana Badovinac
(autor)
Domagoj Vražić
(autor)
Larisa Musić
(autor)
Darije Plančak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE